Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 15 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 15 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Sodium chloride (0.9%) provides isotonic sodium and chloride ions, expanding extracellular fluid volume via osmotic retention of water. Potassium chloride (0.15%) supplies potassium ions necessary for transmembrane electrochemical gradients, maintenance of cellular membrane potential, and neuromuscular function. Combination corrects hypovolemia and hypokalemia.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous infusion: 500-1000 mL as needed to correct fluid and electrolyte deficits; rate adjusted based on patient's clinical status, typically 1-2 L/day for maintenance. Maximum rate: 20 mEq/h potassium.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Not applicable as a pharmacokinetic parameter for electrolyte solutions; the elimination half-life of infused sodium, chloride, and potassium is approximately 2-4 hours, reflecting renal clearance and distribution kinetics. In clinical context, steady-state electrolyte concentrations are achieved within 1-2 hours of continuous infusion.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Sodium and chloride are primarily excreted renally: >90% of filtered sodium and chloride are reabsorbed in the kidneys; excess is excreted in urine. Potassium is mainly excreted renally (approximately 90%), with minor fecal (10%) and negligible biliary elimination.
Category C
Category A/B
Electrolyte
Electrolyte